Comparative Efficacy of Topical Curcumin and Triamcinolone for Oral Lichen Planus: A Randomized, Controlled Clinical Trial
Original Article
Comparative Efficacy of Topical Curcumin and
Triamcinolone for Oral Lichen Planus: A Randomized,
Controlled Clinical Trial
Seid Javad Kia1, Shiva Shirazian2, Arash Mansourian3, Leila Khodadadi Fard4, Sajjad Ashnagar5
1Assistant Professor, Department of Oral Medicine, Faculty of Dentistry, Guilan University of Medical Sciences, Guilan, Iran
2Assistant Professor, Department of Oral Medicine, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran Iran
3Associate Professor, Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran;
Department of Oral Medicine, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
4Dentist, Faculty of Dentistry, Guilan University of Medical Sciences, Guilan, Iran
5Student, Scientific Research Center, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
Abstract
\\
Corresponding author:
A. Mansourian, Dental Research
Center,
Dentistry
Research
Institute, Tehran University of
Medical Sciences, Tehran, Iran;
Department of Oral Medicine,
School of Dentistry, Tehran
University of Medical Sciences,
Tehran, Iran
Received: 3 May 2015
Accepted: 16 October 2015
Objectives: Lichen planus (LP) is a chronic inflammatory mucocutaneous disease. Its
treatment is often symptomatic and includes topical and systemic corticosteroids. Although
corticosteroid therapy is usually successful, it has side effects and thus, an alternative
treatment is favorable. The aim of this study was to compare the efficacy of topical curcumin
and triamcinolone for treatment of oral lichen planus (OLP).
Materials and Methods: In this study, 50 patients (36 women and 14 men) in the age range
of 38 to 73 years with OLP were randomly divided into two groups. Each group received
0.1% triamcinolone or 5% curcumin oral paste three times a day for four weeks. Assessment
of the appearance score and severity of pain was done at baseline and at the end of two and
four weeks and recorded in the patients’ questionnaires. The data were analyzed by SPSS
17 software, using the Mann-Whitney and Spearman’s tests.
Results: With respect to pain reduction, nine patients (36%) in the curcumin group and
eight patients (32%) in the triamcinolone group showed complete remission. With respect
to the appearance score, one patient (4%) in each group showed complete remission. No
statistically significant difference was noted between the two groups.
Conclusion: Application of curcumin is suggested for treatment of OLP because of its
desirable anti-inflammatory effects and insignificant side effects.
Keywords: Curcumin; Lichen Planus; Triamcinolone
Journal of Dentistry, Tehran University of Medical Sciences, Tehran, Iran (2015;Vol. 12, No. 11)
INTRODUCTION
Oral lichen planus is an immune-mediated
disease of unknown etiology with the mediation
of T cells [1], in which the symptoms of patients
decrease with an increase in CD4⁺ counts [2].
Oral lichen planus lesions can be of reticular,
papular, plaque-like, bullous, erythematous
(atrophic) and ulcerative forms.
www.jdt.tums.ac.ir November 2015; Vol. 12, No. 11
Ulcerative lesions are the most debilitating form
of OLP [3], which develop painful symptoms
and interfere with eating, speaking, swallowing
and tooth brushing [4]. Corticosteroids are
usually successful for controlling the symptoms
of the disease [5]; but because of the side effects
of long-term corticosteroid therapy such as
secondary
candidiasis,
telangiectasia,
789
Journal of Dentistry, Tehran University of Medical Sciences
hypothalamic–pituitary–adrenal
suppression
[6,7], muco-cutaneous atrophy and increased
potential of systemic absorption, it may be better
to avoid their long-term use [8].
Curcuma longa is a perennial plant belonging to
Zingiberaceae family [9]. It has been used for
centuries in the Indian traditional medicine for
its anti-inflammatory effects [10]. Its main
constituents include three curcuminoids including curcumin (the primary ingredient and the
one responsible for its yellow color and antiinflammatory effect), demethoxycurcumin and
bisdemethoxycurcumin.
Chainani-Wu in a systematic review [11], and
others [9, 12-16] confirmed the antiinflammatory, antioxidant, wound healing and
anticarcinogenic effects as well as safety of
curcumin.
Clinical studies assessing curcuminoids have
evaluated its utilization in inflammatory
conditions such as rheumatoid arthritis,
postsurgical inflammation and chronic uveitis
[11]. The curcuminoids are safe even in high
doses and only a few side effects have been
reported [11].
Since oxidative stress may play a role in
pathophysiology of OLP [17], and by noting that
OLP is a chronic inflammatory disease [18], the
herbs which have both anti-inflammatory and
antioxidant properties may efficiently control
OLP.
Chainani-Wu et al, in 2007 and 2012 assessed
the efficacy of systemic administration of
curcuminoids for treatment of OLP [10, 19].
Efficacious results were obtained in controlling
the signs and symptoms of OLP using high
doses of this herb. Concerning noticeable side
effects reported by patients who used
corticosteroids [20], chronic nature of OLP, risk
of oral candidiasis upon usage of topical
corticosteroids, and fewer side effects, safety
and
anti-inflammatory
properties
of
curcuminoids, we aimed to clinically evaluate
the efficacy of curcuminoids for treatment
of OLP, compared with conventional
corticosteroid therapy.
790
Kia et al.
MATERIALS AND METHODS
This clinical trial was conducted on 50 patients
(36 women and 14 men) in the age range of 38
to 73 and a mean age of 50.66 years. The
patients had clinical signs of OLP (atrophic and
ulcerative forms), and the disease was
confirmed by clinical and histopathological
examination.
The exclusion criteria were pregnancy and
lactation, current use of anticoagulants or
antiplatelet agents (curcumin has inhibitory
effects on platelet aggregation) [21], current
orthodontic treatment, history of gastric ulcers,
duodenal ulcers, gallstones (curcumin may
induce gastric irritation and stimulate gall
bladder constrictions) [22], hepatic diseases
(curcumin may cause hepatotoxicity in some
mammals including mice and rats) [11], any
existing malignancy or viral infections in the
mouth, history of topical treatment for OLP in
the past two weeks or any systemic treatment for
OLP in the past four weeks, taking azathioprine,
cyclosporine or receiving Psoralen plus
ultraviolet A (PUVA), ultraviolet A (UVA) or
ultraviolet B (UVB) radiation in the past month
and history of allergy to corticosteroids or
curcumin [6].
The crushed roots of C. longa L. were purchased
from a drugstore in Rasht city in Iran and
identified by a research fellow.
The ground herbal root (1g) was extracted using
10 mL of 96% ethanol boiling in a water bath for
three minutes and the least volume of solvent
was added to the given aliquot. Each sample was
centrifuged at 8000g for 10 minutes; then the
supe (...truncated)